These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 26666938

  • 1. Risk Factors and Outcomes for Intestinal Carriage of AmpC-Hyperproducing Enterobacteriaceae in Intensive Care Unit Patients.
    Poignant S, Guinard J, Guigon A, Bret L, Poisson DM, Boulain T, Barbier F.
    Antimicrob Agents Chemother; 2015 Dec 14; 60(3):1883-7. PubMed ID: 26666938
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital.
    Torres-Gonzalez P, Cervera-Hernandez ME, Niembro-Ortega MD, Leal-Vega F, Cruz-Hervert LP, García-García L, Galindo-Fraga A, Martinez-Gamboa A, Bobadilla-Del Valle M, Sifuentes-Osornio J, Ponce-de-Leon A.
    PLoS One; 2015 Dec 14; 10(10):e0139883. PubMed ID: 26431402
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Extended spectrum beta-lactamase producing Enterobacterales faecal carriage in a medical intensive care unit: low rates of cross-transmission and infection.
    Prevel R, Boyer A, M'Zali F, Cockenpot T, Lasheras A, Dubois V, Gruson D.
    Antimicrob Resist Infect Control; 2019 Dec 14; 8():112. PubMed ID: 31333839
    [Abstract] [Full Text] [Related]

  • 7. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
    Goodman KE, Simner PJ, Tamma PD, Milstone AM.
    Expert Rev Anti Infect Ther; 2016 Dec 14; 14(1):95-108. PubMed ID: 26535959
    [Abstract] [Full Text] [Related]

  • 8. ESBL/AmpC-producing Enterobacteriaceae in households with children of preschool age: prevalence, risk factors and co-carriage.
    van den Bunt G, Liakopoulos A, Mevius DJ, Geurts Y, Fluit AC, Bonten MJ, Mughini-Gras L, van Pelt W.
    J Antimicrob Chemother; 2017 Feb 14; 72(2):589-595. PubMed ID: 27789683
    [Abstract] [Full Text] [Related]

  • 9. Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization.
    Vodovar D, Marcadé G, Rousseau H, Raskine L, Vicaut E, Deye N, Baud FJ, Mégarbane B.
    Infection; 2014 Aug 14; 42(4):743-8. PubMed ID: 24728816
    [Abstract] [Full Text] [Related]

  • 10. ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome.
    Emmanuel Martinez A, Widmer A, Frei R, Pargger H, Tuchscherer D, Marsch S, Egli A, Tschudin-Sutter S.
    Infect Control Hosp Epidemiol; 2019 Apr 14; 40(4):408-413. PubMed ID: 30786948
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?
    Canoui E, Tankovic J, Bige N, Alves M, Offenstadt G.
    Med Mal Infect; 2014 May 14; 44(5):235-7. PubMed ID: 24780641
    [No Abstract] [Full Text] [Related]

  • 13. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
    Dickstein Y, Edelman R, Dror T, Hussein K, Bar-Lavie Y, Paul M.
    J Hosp Infect; 2016 Sep 14; 94(1):54-9. PubMed ID: 27392978
    [Abstract] [Full Text] [Related]

  • 14. Treatment of infections caused by carbapenemase-producing Enterobacteriaceae.
    Rodríguez-Baño J, Cisneros JM, Gudiol C, Martínez JA.
    Enferm Infecc Microbiol Clin; 2014 Dec 14; 32 Suppl 4():49-55. PubMed ID: 25542052
    [Abstract] [Full Text] [Related]

  • 15. [Laboratory detection of carbapenemase-producing Enterobacteriaceae].
    Cercenado E.
    Rev Esp Quimioter; 2015 Sep 14; 28 Suppl 1():8-11. PubMed ID: 26365726
    [Abstract] [Full Text] [Related]

  • 16. The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during a Hospital Stay.
    Tamma PD, Kazmi A, Bergman Y, Goodman KE, Ekunseitan E, Amoah J, Simner PJ.
    Antimicrob Agents Chemother; 2019 Aug 14; 63(8):. PubMed ID: 31138574
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Asymptomatic colonization with carbapenem resistant enterobacteriaceae (CRE) in ICU patients and its associated risk factors: Study from North India.
    Datta P, Gupta V, Singla N, Chander J.
    Indian J Med Microbiol; 2015 Aug 14; 33(4):612-3. PubMed ID: 26470985
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.